Innate immune system stimulants (innate adjuvants) offer complementary approaches to vaccines and antimicrobial compounds to increase host resistance to infection. The authors established fetal bovine intestinal epithelial cell (BIEC) cultures to screen natural product and synthetic compound libraries for novel mucosal adjuvants. They showed that BIECs from fetal intestine maintained an in vivo phenotype as reflected in cytokeratin expression, expression of antigens restricted to intestinal enterocytes, and induced interleukin-8 (IL-8) production. BIECs could be infected by and support replication of bovine rotavirus. A semi-high-throughput enzyme-linked immunosorbent assay-based assay that measured IL-8 production by BIECs was established and used to screen commercially available natural compounds for novel adjuvant activity. Five novel hits were identified, demonstrating the utility of the assay for selecting and screening new epithelial cell adjuvants. Although the identified compounds had not previously been shown to induce IL-8 production in epithelial cells, other known functions for 3 of the 5 were consistent with this activity. Statistical analysis of the throughput data demonstrated that the assay is adaptable to a high-throughput format for screening both synthetic and natural product derived compound libraries. (Journal of Biomolecular Screening 2006:664-671) 
INTRODUCTION

T
HE INTESTINAL MUCOSA is the main entry site for many pathogens, which include viruses such as rotavirus, 1 bacteria such as Shigella and Salmonella species, 2 and parasites such as Cryptosporidium parvum. 3 These agents cause moderate to severe gastroenteritis. Viral enteritis is the leading cause of infant mortality in developing countries due to severe dehydration and electrolyte loss. 1 A prerequisite for infection by these agents is their infection/penetration of the epithelial cell barrier lining the luminal surface of the gut mucosa. [1] [2] [3] Epithelial cells represent a formidable barrier against most microbes because of unique physical (barrier function of the epithelial monolayer), chemical (mucus secretions), and immunological mechanisms (release of inflammatory/immune mediators). These activities are part of the innate immune system and, for the most part, are effective in preventing/reducing infection by a wide array of microorganisms. Enhancing these innate functions represents a complementary approach to vaccines and antimicrobial agents in the development of new measures to counter mucosal infection. [4] [5] [6] One approach to identify new innate adjuvants is to use epithelial cell cultures to screen the many synthetic and natural compound drug discovery libraries that have been and continue to be developed. Epithelial cell tumor lines represent the easiest and most consistent source for such assays and have been used in high-throughput screens for compounds that affect barrier functions of epithelial cells. 7 Although obviously useful for many types of screens, transformed cells may not reflect all innate functions of the primary epithelial cell. As such, primary and early passage epithelial cells from specified regions of the gut mucosa may be preferable for such screens, but their isolation and propagation can be technically challenging. Also, the animal source for the cells is critical. For example, if a goal of a screen is the identification of a compound that might reduce infection by a specific pathogen in humans, use of primary human epithelial cells would be best, but these are not easily obtained. If cells are obtained from animal models, it is critical that the disease induced by the pathogen in the animal closely mirrors the disease in humans. Although mice are the most common laboratory animal and provide the lowest cost for such experiments, the progression of mucosal diseases induced by many common pathogens in mice are quite different from that which occurs in humans. For example, Salmonella enterica serovar typhimurium does not cause enterocolitis in mice as it does in humans, even though this bacterium infects mice via the gut mucosa. 8 In contrast to mice, S. typhimurium 8 induces severe enteritis in young bovine calves, similar to that seen in humans. Other mucosal pathogens, such as C. parvum and rotavirus, also cause similar disease in calves and humans. 3, 9 Thus, bovine calves offer a complementary animal model for the development of countermeasures against some mucosal pathogens. Here, we report on the generation of an early passage bovine small intestinal epithelial cell (BIEC) culture obtained from the fetal ileum, which supported infection by bovine rotavirus. The cells could be kept at least 11 passages in culture while maintaining their cytokeratin expression as a marker for epithelial cells. Antibodies generated against these cells stained epithelial cells of the bovine small intestine, particularly enterocytes at the tips of the intestinal villi. Upon stimulation with bacterial lipopolysaccharide (LPS), BIECs produced interleukin-8 (IL-8) mRNA when analyzed by reverse transcriptase RT PCR (RT-PCR). Migration and enzymelinked immunosorbent assay (ELISA) assays confirmed the production of IL-8 protein following LPS treatment of the BIECs. A screening assay was developed that measured IL-8 production by BIECs in a 96-well plate format and was found to meet the criteria for a high-throughput assay. In a preliminary screen of commercially available natural products, 5 compounds were identified that induced IL-8 production by BIECs. None of the 5 compounds had previously been shown to induce IL-8 in epithelial cells, but known functions of 3 of these compounds were consistent with this activity.
MATERIAL AND METHODS
Generation of primary BIECs
BIECs were harvested from sterile intestine sections collected from bovine fetuses. The luminal surface of the small intestine was exposed, and meconium was removed by flushing with ster- 2 . Cells that grew from these cultures were initially characterized as epithelial cells by their morphological features (polarized morphology) as well as epithelial cell-specific cytokeratin staining using the cytokeratin-specific antibodies AE1 and AE3 (Biomeda, Foster City, CA). Both Biomeda antibodies were generated against human cytokeratins and are considered to recognize a wide spectrum of normal and neoplastic mucosal epithelial cells. AE1 sees members of the acidic subfamily and AE3 of the basic subfamily of cytokeratins, and both cross-react with the bovine proteins (M. A. Jutila, unpublished observations, unreferences).
Generation of monoclonal antibodies against BIECs
Mice were immunized intraperitoneally using 3 × 10 6 to 5 × 10 6 ΒΙΕCs 3 times at 3-week intervals. Four days after the last boost, spleens were harvested, and isolated spleen cells were fused with SP2/0 cells as previously described. 10 Supernatant fluids from the resulting hybridomas were screened by fluorescent-activated cell sorter (FACS) analysis on the cultured epithelial cells. Secondary screens were done by immunoperoxidase staining of bovine gut tissue sections or preparations of cultured BIECs and analyzed by microscopy as described previously. 11 Briefly, acetone-fixed multiwell culture preparations or frozen tissue sections were first pretreated with 5% rabbit serum (RS) in phosphate-buffered saline (PBS) for 15 min and incubated with 100 µl of monoclonal antibody (mAb) supernatant fluid for 30 min at room temperature in a humidified chamber. The slides were washed in PBS/2% RS and incubated with biotin-conjugated goat antimouse Ig 2nd stage (TAGO, Inc., Burlingame, CA) for 30 min at room temperature in a humidified chamber. The slides were incubated with avidin-conjugated horseradish peroxidase (TAGO) for 20 min, washed, and incubated in specific substrate solution (TAGO). Developed slides were counterstained with hematoxylin.
Neutrophil migration assay using LPS-stimulated BIEC culture supernatant fluids
BIECs were cultured on Falcon tissue culture 6-well plates (Fischer Scientific) to confluency and stimulated for 4 h with LPS (Escherichia coli 011B4; Sigma; 1 µg/ml). Monolayers were washed twice with epithelial cell media without LPS, and new media were added to the wells and cultured for 24 h. Supernatant fluids were harvested, and aliquots were frozen at -80° C prior to use.
Bovine neutrophils were isolated from 80 ml of blood using a Histopaque (Sigma) gradient centrifugation. Briefly, whole blood was separated from plasma by centrifugation, and the plasma was removed. Red blood cells (RBCs) were removed by hypotonic lysis. Cells were centrifuged at 1800 rpm in a Sorvall centrifuge using a GS3 rotor. The RBC lysis step was repeated accordingly, and the white blood cell (WBC) pellet was resuspended in 10 ml of HBSS. A Histopaque density gradient was set up as follows: 15 ml of Histopaque 1077 (Sigma) was underlayed with a mix of 7.5 ml of Histopaque 1077 and 7.5 ml Histopaque 1119 (Sigma). Ten milliliters of the WBC suspension was loaded onto the gradient and centrifuged for 25 min at 1400 rpm in a Sorvall RT6000B table-top centrifuge. Lymphocytes were located at the interface of the 2 Histopaque layers and removed by suction. The granulocyte pellet was washed once in 50 ml HBSS and then resuspended in X-Vivo 15 medium (BioWhittaker, Rockland, MN) at a concentration of 1 × 10 7 cells/ml. Costar Transwell ® plates (Fisher Scientific) with 5-µm pore sizes were used for the migration assays, as previously described. 11 Briefly, 600 µl of cell supernatant fluid, X-Vivo 15 as a control for passive migration, was placed in the lower well, and the plates were incubated at 37° C for 30 min to equilibrate the temperature. Inserts were carefully set into wells containing the BIEC supernatant fluids, and 100 µl of cells was placed into the top chamber. As a 100% control, 100 µl of cells was placed in the bottom of 1 well not containing an insert, and 600 µl of X-Vivo 15 was added. Plates were placed in a tissue culture incubator at 37 °C for 2 h. After the incubation period, the top chamber was carefully removed and discarded. Plates were then set on ice for 10 to 20 min. Polystyrene beads (15 µm; Polysciences, Inc., Warrington, PA) were resuspended in cold PBS, and 100 ml of this bead suspension was then added to each well of the migration assay. The contents of each well (cells and beads) was collected into FACS tubes, centrifuged, and resuspended in 500 µl PBS for analysis on a FACSCalibur (BD BioScience, San Jose, CA). A minimum of 50,000 events was collected for each sample. Leukocyte migration was quantified as a ratio of cells to beads, as identified by their distinctive light scatter profiles. Percentage migration of input cells was determined by comparing neutrophil/bead ratios of each migration well to the 100% control in which all of the input cells were placed in the lower well. Each assay was repeated at least 3 times.
Chemokine-specific RT-PCR
BIECs were cultured on 6-well plates to confluency and stimulated with 1 µg/ml LPS (011B4 E. coli; Sigma) for 4 and 24 h. Total RNA was isolated from BIEC using the TRIzol reagent (GIBCO BRL; Invitrogen, Carlsbad, CA) according to the manufacturer's protocol. For 1st-strand cDNA synthesis, 1 to 3 µg of total RNA was subjected to reverse transcription using Superscript II RT (GIBCO BRL) and oligo-dT for priming. Gene-specific PCR followed using specific primers for bovine β-actin and IL-8 using Platinum Taq-polymerase (GIBCO-BRL) following a hot start procedure with annealing temperatures at 58 °C for 45 s, extension temperature at 72 °C for 1 min for 26 to 30 cycles, with a final extension at 72 °C for 7 min.
Sequences for gene-specific primer were as follows:
Primers were designed based on the sequences available in the NCBI bovine EST database.
Viruses and cell culture infection
Bovine rotavirus strain B641 was originally isolated from a diarrheic calf and adapted to MA104 cells. 12 For infection, BIECs were cultured on collagen-coated (Sigma) 6-well plates and infected with a multiplicity of 0.1 pfu/epithelial cell. Infected cultures were maintained in serum-free X-Vivo 15 media in the presence of 0.2 mg/ml trypsin. Infection was confirmed by immunofluorescence staining using the rotavirus VP6 specific antibody E4. 13 Briefly, infected cells were fixed in acetone after 18 h of infection. The cell monolayer was rehydrated in PBS/1% bovine serum albumin (BSA) solution for 10 min and E4 antibody added and incubated at room temperature for 30 min. The cells were then washed 5 times with PBS/1% BSA. Detection of primary antibody was done with a fluorescein isothiocyanatelabeled antimouse antibody (Jackson ImmunoResearch, West Grove, PA), incubated for 30 min on the cells at a final dilution of 1:250 in PBS plus 2% horse serum. Analysis was performed by fluorescence microscopy. The cytokeratin-specific antibody preparation AE1+3 (Biomeda) was used as a positive control in the immunofluorescence analysis.
IL-8 protein screening assay
BIECs were first cultured for 24 h at 1.2 × 10 6 cells/ml in 96-well Falcon plates using epithelial cell growth medium. The cells were washed in DMEM and then incubated in triplicate with varying concentrations of different natural compounds from a 280-compound library (TimTec, Inc., Newark, DE), multiple doses of LPS (E. coli 011B4; Sigma) or medium alone. The TimTec compounds were resuspended in DMSO. Testing of the compounds was done in medium containing 1% or less DMSO, which had no effect on the BIECs. Cells were incubated for 24 h, and supernatant fluid was collected for analysis of IL-8. IL-8 production by BIECs was determined using an IL-8 ELISA kit (R&D Systems, Minneapolis, MN).
Statistics
The Z′ statistic measures the quality of a high-throughput screening (HTS) assay by comparing data variation and the signal dynamic range.
14 Z′ was calculated using the equation Z′ = 1 -(3 × SD positive control + 3 × SD negative control)/(mean positive control -mean negative control). To calculate Z′, the LPS data (250 ng/ml) were used as the positive control and medium alone was used as the negative control.
RESULTS
Establishment and characterization of BIECs
Assuming that contamination would be problematic in harvesting epithelial cells from calf intestinal tissues, sterile fetal intestines were used and cultures of primary and early passage epithelial cells were established. Following selection in epithelial cell growth medium, nearly pure cultures of cytokeratin-positive epithelial cells (Fig. 1A) were maintained through 11 passages (data not shown). Growth rates and formation of tight monolayers slowed in late passage cultures (data not shown). To determine if the cultured epithelial cells maintained at least a partial in vivo phenotype, monoclonal antibodies were raised against the cells and used to stain gut mucosal tissue by immunoperoxidase. MAb Bep1-1-10, which avidly stained virtually all of the cells in culture (Fig. 1C) , specifically stained epithelial cells lining the intestinal villi, crypts, and glands (Fig. 1D) . Terminal enterocytes of the intestinal villi were clearly positive for the Bep1-1-10 mAb, suggesting that the epithelial cell cultures maintained at least some of the in vivo phenotype of mucosal cells, the 1st contact of many mucosal infectious agents. Another approach to determine if the epithelial cell cultures maintained an in vivo phenotype was to examine their ability to support infection by bovine rotavirus. Cultures were infected at a low pfu/cell ratio (0.1 pfu/epithelial cell). A titer of 6 × 10 4 pfu/ml was generated following 3 passages on BIECs. Using a mAb specific for bovine rotavirus capsid protein VP6, infected cultures were stained for viral antigen and examined for cytopathic effect. Cytopathic effect occurred between 48 and 72 h after infection in about 10% of cells (data not shown; Fig. 2 ). Viral antigen was detected in foci of the cytopathic effects (Fig. 2) .
Expression of IL-8 by LPS-stimulated BIECs
Epithelial cells have many innate defense functions, one of which is induced production of IL-8, which attracts myeloid cells to a site of infection. LPS is a potent inducer of IL-8 production by epithelial cells 15 and was used to treat confluent cultures of BIECs grown in 6-well plates for 4 h. Total RNA was isolated from the BIEC and IL-8 transcripts measured by RT-PCR. As shown in Figure 3 , LPS-treated BIECs expressed IL-8 mRNA. We then tested whether IL-8 protein could be detected in supernatant fluid from LPS-activated BIECs. BIECs were treated with different concentrations of LPS for 24 h, and supernatant fluid was collected and analyzed for IL-8 by a quantitative ELISA assay. As shown in Figure 4 , LPS induced a dose-dependent production of IL-8. Finally, to determine if functional levels of IL-8 were produced, supernatant fluid was collected from LPS-treated BIECs and assayed for neutrophil chemotactic activity in a multiwell, chemotaxis chamber assay. As shown in Figure 5 , potent neutrophil chemotactic activity was evident in the supernatant fluid from LPS-treated BIECs. Thus, BIECs respond to LPS by production of functional levels of IL-8.
Development of a high-throughput BIEC assay for epithelial cell adjuvants
We adapted the IL-8 ELISA assay described above to a semi-HTS format. Briefly, epithelial cells were grown in wells of 96-well plates for 1 day, washed, and treated with LPS as a positive control, medium alone as a negative control, or a series of test compounds. We tested the utility and consistency of the assay in preliminary screens of natural compounds purchased from TimTec, Inc. This library was first screened by a rotavirus infectivity assay (M. Shaneyfelt, A. Burke, M. A. Jutila, and M. Hardy, 2005, unpublished manuscript, unreference) and an IL-8 ELISA assay using continuous epithelial cell lines (data not shown). Select compounds were then screened on BIECs using the IL-8 ELISA assay. Figure 6 shows a dose analysis of 5 compounds that showed activity > 25% of the LPS control, as well as the results of 10 other compounds, in the high-throughput IL-8 ELISA assay. The 5 compounds with activity were ouabain (no. 160), digoxigenin (no. 192), acetylstrophanthidin (no. 42), demecolcine (no. 229), and cantharidin (no. 244). None of these compounds had previously been shown to affect cytokine production in epithelial cells. All compounds had activity in highnanogram to low-microgram concentrations (Fig. 6) .
To determine if the assay met the criteria for a high-throughput assay, Z′ values 14 were calculated from the assays shown in Figure 6 . A Z′ > 0 is a prerequisite, with values equal to or greater than 0.5 being ideal for a high-throughput screen.
14 The 2 assays shown in Figure 6 have Z′ values of 0.699 and 0.785, indicating that this assay not only is useful for identifying novel epithelial cell agonists but also exceeds at least this criteria for a high-throughput assay.
DISCUSSION
To facilitate identification of new compounds that enhance innate immune responses against acute infection of the gut mucosa, we developed procedures to isolate, propagate, and adapt early passage gut mucosa epithelial cell cultures (BIECs) into a high-throughput assay. The high-throughput assay measures IL-8 release from stimulated epithelial cells and can be used to screen compound libraries for potential stimulants of the gut mucosa. The BIECs were isolated from fetal tissues to minimize potential contamination during isolation. We also hypothesized that cells from fetal tissue would have greater growth potential than cells isolated from adults. Using standard protocols to generate epithelial cell cultures, we routinely established cultures that were > 90% pure epithelial cells, as determined by selective expression of epithelial cytokeratin. We also showed that BIECs, similar to in vivo epithelial cells, could be infected by bovine rotavirus and mAbs raised against the BIEC-stained epithelial cells at the tips of microvilli, crypts, and glands of the gut mucosa. As shown for epithelial cells in other models, 15 LPS induced functional levels of IL-8 from the BIECs. Cultures of similar BIEC preparations have been shown to form a tight monolayer characteristic of epithelial cells and support C. parvum infection (M. S. Abrahamsen, personal communication, unreferences). Thus, by multiple criteria, the procedures outlined here lead to cultures of BIECs that closely reflect in vivo epithelial cells of the intestinal villi, the point of infection by many pathogens.
Using a 96-well plate-based assay, natural products purchased from TimTec, Inc. were screened for IL-8-inducing activity in BIECs. Upon dose analysis of select compounds from initial screens, 5 were shown to induce dose-dependent IL-8 release by BIECs. These included ouabain, digoxigenin, acetylstrophanthidin, demecolcine, and cantharidin. There are no easily identifiable reports in the literature describing this activity (induced IL-8 production by bovine epithelial cells) for any of the 5 compounds. However, a link between the known activities of the compounds or similar derivatives can be made for 3 of the 5 compounds. For example, ouabain binds and signals through the Na + /K + -ATPase (sodium pump) on a variety of cells. 16 A major downstream response to ouabain is activation of AP-1 and NFκB transcription factors, which control gene expression for a variety of cytokines including IL-8. 17, 18 Directly relevant to our findings are reports that oubain induces IL-6, IL-1, and tumor necrosis factor α production by peripheral blood mononuclear cells. 18 Thus, because of the function and relevance of the sodium pump to epithelial cells, it is not surprising that ouabain induces IL-8 production by BIECs. Interestingly, acetylstrophanthidin is an inhibitor of the Na + /K + -ATPase, having opposing activities of ouabain on ion transport in epithelial cells. 19 We show that it is nearly as potent as ouabain in inducing IL-8 production in epithelial cells. This suggests that ion transport may not be important for induction of IL-8 via the Na
The known activities of cantharidin, although not reported to include inducing cytokine release by gut epithelial cells, are consistent with our results as well. Cantharidin is a defensive compound found within the hemolymph of blister beetles. It is a potent protein phosphatase 1 and 2 alpha inhibitor. 20 When applied to the skin, cantharidin causes acantholysis and blister formation, which is associated with inflammatory cytokine production and inflammatory cell recruitment. 20 Inducing IL-8 release from BIECs is consistent with these activities.
A link between the known activities of the other 2 compounds to the findings reported here is not as obvious. Demecolcine destabilizes microtubules in mammalian cells, including epithelial cells, 21 but induction of cytokine release has not been reported for this compound. However, the effects of demacolcine are very modest at best (only 25% of the effect of LPS); thus, its effects may be difficult to confirm. Digoxigenin is a common reagent for labeling DNA, but we have found no reports that it induces signaling in cells. Interestingly, digoxigenin was originally isolated from the same plant species as oubain (digitalis sp.), a plant thought to produce immune-modulating factors. The IL-8 response following digoxigenin treatment is comparable to LPS; thus, further analysis of its potential mode of action is warranted.
In summary, we have established a straightforward, highly quantitative assay for screening novel adjuvants for epithelial cells. In a preliminary screen of a limited number of natural compounds, 5 compounds were identified that previously had not been shown to induce IL-8 production by intestinal epithelial cells, illustrating the utility of the assay in identifying novel epithelial cell agonists. Aside from the maintenance and plating of the epithelial cells, all other aspects of the assay are adaptable to robotics; thus, it can be used in a high-throughput approach. As such, we have initiated screens of commercial, synthetic, druglike compound libraries using BIECs and the IL-8 ELISA high-throughput assay. Obviously, compounds that induce overt IL-8 production by epithelial cells would likely not be used prophylactically (could cause chronic inflammation) but could, perhaps, be used therapeutically. We also anticipate identifying modest inducers of IL-8, which increase the responsiveness of the epithelium. These compounds could potentially be taken 
